Get started

AMGN

Repatha will bring major volume and take AMGN to new heights.Repatha (AMGN) and Praluent (Regeneron (REGN)/Sinofy (SNY)) are two PCSK9 inhibitors, a new class of drugs to treat hypercholesterolemia more effectively than previously possible. This will trigger a HCV-like battle between the two as both have high efficacy. Both have room to share the market, allowing both to make a significant amount of money on these blockbuster drugs. Unlike the HCV battle where GILD had more than a year of first-to-market status, Praluent will only have a month of such status assuming REGN/SNY can capitalize on that extra time to quickly bring it to the US market faster than AMGN. However, Repatha is expected to hit the EU market sooner, so it's a fair tradeoff as both will be able to get some good traction. Additional difference could be in the pricing strategy of Praluent being cheaper due to lower dosing, however Repatha has a slightly higher efficacy (61% vs 56% Praluent) and has noted a possible 50% reduction in cardiovascular disease. If AMGN is able to prove these claims with a large post-marketing study, Repatha will have a significant advantage due to the added secondary benefit and can easily command a higher price point. Important Repatha Dates: June 10 ADCOM Aug 27 PDUFA Important Praluent Dates: June 9 ADCOM July 24 PDUFA MM's taking this down to $157 is a bargain given the strength of the company's overall pipeline. At the very least, we should see some action heading into the ADCOM dates and both drugs are expected to easily get positive recommendations. EMA has already given positive recommendations for both drugs in May. EMA approval for Repatha is expected in September, shortly after the FDA approval.
NASDAQ:AMGNLong
by Elemental
4
BIS- Inverse Off IBB Could It be? A Double Bottom In The Making?4-22 Could It Be? Is this where we carve out a double bottom? If so then IBB (longside) MAY be carving out a double top. Remember, going long this is gaining short exposure in the bios. BIIB (Biogen) reports so be aware it could have an impact on this issue. Chart wise its all about an upside crossover of the green line. Feel free to follow on TWTR at @AmazingPatterns For informational and educational purposes only, these are not recommendations, trade at your own risk.
NASDAQ:BIS
by Amazingpowerpatternguy
REGN- See How Important The Use Of Trend Channels Are? 10-30 For those interested in buying support, especially know considering how short term extended things are these days. Its all about the blue line. It also helps define ones entry risk here. If buying here you are buying 20 points away from a support zone (thanks anyway I say). Given this issue is tagging a trend channel resistance zone? That is all the more reason to let them come to you in the form of a pullback. After all to a chartist the adage of buy support and sell resistance is a classic mantra isn't it? Even more so when you have an issue that just tagged the trend channel resistance zone. Sure its pulling back but still needs more chart time. This chart is also a good example of how the trend channel keeps you away from going long at the wrong time and AFTER a run has been made already. The use of trend channels are your best friend. Not only do they help you manage the overall trend they keep you from getting emotional at key levels. At resistance? They keep you away from that dreaded fear of missing it AFTER you already missed it emotional trade. At support they keep you away from caving into fear and selling at a support zone. For informational and educational purposes only. These are not recommendations. Trade at your own risk.
NASDAQ:REGN
by Amazingpowerpatternguy
1